Madrigal, CSPC sign licensing agreement for oral GLP-1 agonist
CSPC will receive an upfront payment of $120m and could earn up to $2bn in milestone payments, alongside royalties on net sales.

A leading resource for the Pharmaceutical industry since 2002
CSPC will receive an upfront payment of $120m and could earn up to $2bn in milestone payments, alongside royalties on net sales.
Give your business an edge with our leading industry insights.
Chemspec Europe 2025 returns to Cologne with expanded exhibition space, enhanced digital tools, and a diverse line-up of industry leaders. This premier event will showcase cutting-edge solutions across key sectors,...
Seal the deal
Excipient evolution shaping pharma innovation
Solving the EDDO guidance puzzle
AI-driven delivery